Establish long-term peer-to-peer partnerships with leading infectious-disease physicians, travel-medicine specialists, vaccinologists, epidemiologists, academic centers, public-health professionals, and other relevant stakeholders. We have leveraged our expertise and capabilities both to commercialize three vaccines, including the world’s first and only chikungunya vaccine, and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease and Zika.